CSL Limited CSL.AX
AU · Australian Securities Exchange · XASX · stock · Healthcare · website
CSL Limited statistics & valuation
Market cap$87.3B
P / S5.6×
P / B5.9×
Dividend yield1.79%
Net margin-16.4%
Return on equity-17.4%
Net debt$9.4B
Enterprise value$70.7B
Earnings yield EBIT/EV3.2%
Return on capital11%
Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Gross margin | 50.8% | 51.5% | 51.5% | 50.9% |
| Operating margin | 19.8% | 19.2% | 18.8% | 16.0% |
| Net margin | -16.4% | 19.5% | 18.0% | 16.7% |
| Return on assets | -7.7% | 7.6% | 6.9% | 6.1% |
| Return on equity | -17.4% | 15.5% | 15.2% | 13.9% |
| Debt / equity | 0.57× | 0.47× | 0.56× | 0.61× |
| Current ratio | 2.21 | 2.46 | 2.18 | 2.01 |
Computed from company filings · AU · as of 2026-06-30. Figures in USD. Facts plus Stocktoria's own computed scores — not investment advice.